Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors

International Journal of Cardiology

Volumn 175, Issue 1, 2014, Pages 90-95

  Sciacqua, Angela ^a   Perticone, Maria ^c   Tripepi, Giovanni ^b   Miceli, Sofia ^a   Tassone, Eliezer J ^a   Grillo, Nadia ^a   Carullo, Giuseppe ^a   Sesti, Giorgio ^a   Perticone, Francesco ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

^c Experimental and Clinical Medicine Experimental and Clinical Medicine   (United States)

Author keywords

Atrial fibrillation; Atrial volume; Chronic kidney disease; Left ventricular hypertrophy

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOCUMENTATION; ECHOCARDIOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART ATRIUM REMODELING; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HOLTER MONITORING; HOSPITAL DISCHARGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; LEFT ATRIUM VOLUME INDEX; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASES; HEALTH SURVEY; HEART ATRIUM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; ATRIAL REMODELING; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84902550547     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.04.259     Document Type: Article

References (37)

1. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification Am J Kidney Dis 39 2002 S1 S266
2. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth et al. American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention Hypertension 42 2011 1050 1065
3. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
4. G. Schillaci, G. Reboldi, and P. Verdecchia High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension Arch Intern Med 161 2001 886 891
5. J.S. Jensen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and K. Borch-Johensen Arterial hypertension, microalbuminuria, and risk of ischemic heart disease Hypertension 35 2000 898 903
6. N.A. Meguid El, and A.K. Bello Chronic kidney disease. The global challenge Lancet 365 2005 331 340
7. A. Sciacqua, A. Scozzafava, and A. Pujia et al. Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension Eur Heart J 26 2005 921 927
8. C. Zoccali, R. Maio, G. Tripepi, F. Mallamaci, and F. Perticone Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension J Am Soc Nephrol 17 2006 S64 S68
9. S. Miceli, R. Maio, M. Perticone, F. Mallamaci, and F. Perticone Creatinine and insulin predict cardiac mass in drug-naive hypertensive patients Int J Cardiol 167 2013 519 524
10. M.P. Schlaich, F. Socratous, and S. Hennebry et al. Sympathetic activation in chronic renal failure J Am Soc Nephrol 20 2009 933 939
11. F. Perticone, R. Maio, and C. Cosco et al. Hypertensive left ventricular remodeling and ACE-gene polymorphism Cardiovasc Res 43 1999 192 199
12. G.V. Naccarelli, S.S. Johnston, J. Lin, P.P. Patel, and K.L. Schulman Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States Clin Cardiol 33 2010 270 279
13. D.D. McManus, D.C.M. Corteville, M.G. Shlipak, M.A. Wholeey, and J.H. Ix Relation of kidney function and albuminuria with atrial fibrillation (from the Heart and Soul Study) Am J Cardiol 104 2009 1551 1555
14. U. Baber, V.J. Howard, J.L. Halperin, M.A. Wholeey, and J.H. Ix Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study Circ Arrhythmia Electrophysiol 4 2011 26 32
15. F. Perticone, R. Maio, and C. Ruberto et al. Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension Am J Kidney Dis 52 2008 74 84
16. A. Sciacqua, S. Miceli, and G. Carullo et al. One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients Diabetes Care 34 2011 1406 1411
17. G. Sesti, A. Sciacqua, and A. Scozzafava et al. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients J Hypertens 25 2007 471 477
18. B.H. Lorell, and B.A. Carabello Left ventricular hypertrophy: pathogenesis, detection, and prognosis Circulation 102 2000 470 479
19. K. Wachtell, E. Gerdts, and G.P. Aurigemma et al. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study Blood Press 19 2010 169 175
20. J. Eckstein, S. Verheule, N.M. de Groot, M. Allessie, and U. Schotten Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria Prog Biophys Mol Biol 97 2008 435 451
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
22. A.S. Levey, L.A. Stevens, and C.H. Schmid et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
23. N.G. Vieira-Filho, F.J. Mancuso, and W.A. Oliveira et al. Simplified single plane echocardiography is comparable to conventional biplane two-dimensional echocardiography in the evaluation of left atrial volume: a study validated by three-dimensional echocardiography in 143 individuals Echocardiography 31 2014 265 272
24. R.M. Lang, M. Bierig, and R.B. Devereux et al. Recommendations for chamber quantification Eur J Echocardiogr 7 2006 79 108
25. M.D. Cheitlin, W.F. Armstrong, and G.P. Aurigemma et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography) Circulation 108 2003 1146 1162
26. R.B. Devereux, D.R. Alonso, and E.M. Lutas et al. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings Am J Cardiol 57 1986 450 458
27. R. Marcus, L. Krause, and A.B. Weder et al. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study Circulation 90 1994 928 936
28. R. de Mutsert, K.J. Jaeger, C. Zoccali, and F.W. Dekker The effect of joint exposures: examining the presence of interaction Kidney Int 75 2009 677 681
29. D. Collet Modelling survival data in medical research 1994 Chapman and Hall London 72 85
30. D.W. Hosmer, and S. Lemeshow Assessment of model adequacy Applied survival analysis 1999 Wiley & Sons New York 196 240
31. P. Verdecchia, G. Reboldi, and R. Gattobigio et al. Atrial fibrillation in hypertension: predictors and outcome Hypertension 41 2003 218 223
32. ONTARGET Investigators S. Yusuf, and K.K. Teo et al. Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med 358 2008 1547 1559
33. E.J. Benjamin, D. Levy, and S.M. Vaziri et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
34. T.S. Tsang, M.E. Barnes, B.J. Gersh, K.R. Bailey, and J.B. Sewatd Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden Am J Cardiol 90 2002 1284 1289
35. W. Zhao, T. Zhao, Y. Chen, R.A. Ahokas, and Y. Sun Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats Mol Cell Biochem 317 2008 43 50
36. G. Manjunath, H. Tighiouart, and H. Ibrahim et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community J Am Coll Cardiol 41 2003 47 55
37. M.P. Schneider, T.A. Hua, and M. Böhm et al. Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis J Am Coll Cardiol 55 2010 2299 2307